AstraZeneca PLC 2006 SR
The report outlines AstraZeneca's commitment to corporate responsibility across four key areas: Patients, Products, People, and Performance. Key highlights include the withdrawal of the medicine Exanta for patient safety, ongoing research for a new tuberculosis treatment in Bangalore, and a pilot project in Ethiopia for breast cancer care. The company also introduced a new climate change target aiming for absolute emissions in 2010 to be no greater than in 2000, despite the launch of new therapies. Additionally, the report details efforts in animal welfare, ethical sales practices, and employee safety, noting a decrease in occupational illness rates.
Company: AstraZeneca PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2006
Type: SR
Pages: 40
Back to company
AstraZeneca PLC
Corporate Responsibility Report (Summary)
The report outlines AstraZeneca's commitment to corporate responsibility across four key areas: Patients, Products, People, and Performance. Key highlights include the withdrawal of the medicine Exanta for patient safety, ongoing research for a new tuberculosis treatment in Bangalore, and a pilot project in Ethiopia for breast cancer care. The company also introduced a new climate change target aiming for absolute emissions in 2010 to be no greater than in 2000, despite the launch of new therapies. Additionally, the report details efforts in animal welfare, ethical sales practices, and employee safety, noting a decrease in occupational illness rates.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2006
Reporting Period
Jan 1, 2006 - Dec 31, 2006
Fiscal Year
2006
Published
Jan 1, 2007
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Women in Management
Workplace Fatalities
Employees